TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35843546 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35843546 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 35843739 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35844029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35844029 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35844042 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35845461 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35845461 — Safety Biomarker (SAF): BDNF
Study 35846096 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35846097 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35846215 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35846221 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35846226 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 35846272 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 35846272 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35846272 — Surrogate Endpoint (SUR): Blood pressure
Study 35848614 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35848622 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 35849791 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 35850444 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35850660 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35851282 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35851408 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 35852004 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35852359 — Surrogate Endpoint (SUR): Blood pressure
Study 35852431 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35852619 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 35852656 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 35853681 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35853972 — Surrogate Endpoint (SUR): Blood pressure
Study 35853994 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 35854274 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study 35856671 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 35856671 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 35856671 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35857405 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 35857405 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35857405 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35857405 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35860245 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35860245 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35860587 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35860587 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35860587 — Predictive Biomarker (PRD): Hormone receptor
Study 35861072 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 35861296 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35861370 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35861778 — Predictive Biomarker (PRD): HK2 mRNA
Genes: HK2
Study 35861811 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 35861811 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35861811 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35861811 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35861979 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35861979 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35862024 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35862035 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35862035 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35862126 — Surrogate Endpoint (SUR): Blood pressure
Study 35862141 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35862141 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35866984 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 35867411 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35867947 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35867951 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35867966 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35868533 — Predictive Biomarker (PRD): CYP1B1 mRNA
Genes: CYP1B1
Study 35869124 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study 35869143 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35869143 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 35869143 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 35869143 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study 35869143 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 35869143 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35869143 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35869143 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 35869170 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35869170 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35869170 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35869810 — Surrogate Endpoint (SUR): Serum sodium
Study 35870368 — Surrogate Endpoint (SUR): Blood pressure
Study 35870472 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35871310 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35871922 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 35872509 — Predictive Biomarker (PRD): KMT2D mRNA
Genes: KMT2D; ALR; MLL2; MLL4
Study 35872509 — Predictive Biomarker (PRD): KMT2C mRNA
Genes: KMT2C; HALR; KIAA1506; MLL3
Study 35872693 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35872799 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 35873652 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35874466 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35874564 — Surrogate Endpoint (SUR): Blood pressure
Study 35875816 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35875815 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35876164 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 35876391 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35876391 — Safety Biomarker (SAF): let-7a
Study 35876391 — Predictive Biomarker (PRD): miR-145
Genes: MIR145
Study 35876418 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 35876699 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 35876699 — Predictive Biomarker (PRD): CCL21 mRNA
Genes: CCL21; SCYA21; UNQ784/PRO1600
Study 35876706 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35876829 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 35877091 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 35877091 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35877173 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35877173 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35877767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35878076 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35878676 — Predictive Biomarker (PRD): ERICH3 mRNA
Genes: ERICH3; C1orf173
Study 35878742 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 35878742 — Predictive Biomarker (PRD): IL7 mRNA
Genes: IL7
Study 35879127 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35879335 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 35879765 — Surrogate Endpoint (SUR): Serum creatinine
Study 35879962 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 35880940 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 35880942 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 35881028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35881895 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study 35881895 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35881895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35881967 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 35882382 — Surrogate Endpoint (SUR): Blood pressure
Study 35882447 — Predictive Biomarker (PRD): TGFBR2 mRNA
Genes: TGFBR2
Study 35883236 — Surrogate Endpoint (SUR): Serum creatinine
Study 35883458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35883458 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 35883458 — Predictive Biomarker (PRD): SGK1 mRNA
Genes: SGK1; SGK
Study 35883458 — Predictive Biomarker (PRD): FOXO1 mRNA
Genes: FOXO1; FKHR; FOXO1A
Study 35883458 — Predictive Biomarker (PRD): RANBP1 mRNA
Genes: RANBP1
Study 35886510 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35887529 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35891387 — Predictive Biomarker (PRD): IFIH1 mRNA
Genes: IFIH1; MDA5; RH116
Study 35891387 — Predictive Biomarker (PRD): ZNFX1 mRNA
Genes: ZNFX1; KIAA1404
Study 35891515 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35891697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35892294 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35894077 — Predictive Biomarker (PRD): AKR1B1 mRNA
Genes: AKR1B1; ALDR1; ALR2
Study 35894609 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 35897070 — Surrogate Endpoint (SUR): Serum creatinine
Study 35897078 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35898343 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35898703 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 35899095 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 35899212 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 35899469 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 35900694 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35901272 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 35902169 — Predictive Biomarker (PRD): CAP2 mRNA
Genes: CAP2
Study 35902798 — Surrogate Endpoint (SUR): Pathological complete response
Study 35903636 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 35903678 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35904231 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35904671 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35904853 — Surrogate Endpoint (SUR): Blood pressure
Study 35904878 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35904987 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35904987 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35905198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35907135 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35907135 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35907438 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35908242 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 35909569 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35911547 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 35911702 — Surrogate Endpoint (SUR): Pathological complete response
Study 35913563 — Surrogate Endpoint (SUR): Urinary oxalate
Study 35913657 — Surrogate Endpoint (SUR): Blood pressure
Study 35914222 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35914226 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 35914226 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35914227 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 35914239 — Surrogate Endpoint (SUR): Pathological complete response
Study 35915019 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35915019 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 35915157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35915157 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35915157 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35915419 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35915419 — Predictive Biomarker (PRD): Hormone receptor
Study 35915479 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35916675 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 35918703 — Surrogate Endpoint (SUR): Blood pressure
Study 35918719 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35918722 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35918734 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 35919268 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35919766 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35920161 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35920161 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35921541 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 35921541 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35921817 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study 35922667 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study 35922667 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 35923923 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35923923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 35923926 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35924778 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 35924778 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35924841 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35925583 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 35925612 — Surrogate Endpoint (SUR): Blood pressure
Study 35925612 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35925981 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 35926241 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35926332 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 35926375 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 35926895 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35926895 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35926895 — Surrogate Endpoint (SUR): Blood pressure
Study 35926961 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 35926961 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 35927208 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35927231 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35927795 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study 35928870 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35929414 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35929455 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 35929455 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 35929986 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 35930441 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 35930750 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35930750 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 35930972 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 35931001 — Surrogate Endpoint (SUR): Blood pressure
Study 35931943 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 35931943 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 35931943 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35932388 — Predictive Biomarker (PRD): NEDD8 mRNA
Genes: NEDD8
Study 35932628 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 35932628 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 35933552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35933915 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35934287 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study 35934287 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 35934287 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 35934287 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 35935974 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35935974 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35938545 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35939367 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 35939812 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 35939919 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 35939981 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35940055 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35940055 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 35940055 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35940334 — Surrogate Endpoint (SUR): Blood pressure
Study 35940825 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 35940836 — Surrogate Endpoint (SUR): Blood pressure
Study 35941028 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35941076 — Monitoring Biomarker (MOI): HBV DNA
Study 35941212 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35941212 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35941212 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 35941212 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study 35941284 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35941372 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35941641 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 35941641 — Surrogate Endpoint (SUR): Blood pressure
Study 35941696 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35942508 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35942508 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35942508 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35942675 — Predictive Biomarker (PRD): GJA1 mRNA
Genes: GJA1; GJAL
Study 35943168 — Predictive Biomarker (PRD): STYK1 mRNA
Genes: STYK1; NOK
Study 35943786 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35944181 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35944181 — Predictive Biomarker (PRD): LAT2 mRNA
Genes: LAT2; LAB; NTAL; WBS15; WBSCR15; WBSCR5; HSPC046
Study 35944767 — Surrogate Endpoint (SUR): Blood pressure
Study 35945470 — Surrogate Endpoint (SUR): Blood pressure
Study 35945547 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 35945547 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 35945605 — Surrogate Endpoint (SUR): Blood pressure
Study 35945943 — Predictive Biomarker (PRD): SPIN1 mRNA
Genes: SPIN1; OCR; SPIN
Study 35946431 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 35946927 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35947027 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35948378 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35948844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35948844 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 35948919 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35949152 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 35949290 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 35949358 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP